Literature DB >> 7114296

Ontogeny of blood-brain barrier permeability to, and cerebrospinal fluid sink action on, [14C]urea.

Z Parandoosh, C E Johanson.   

Abstract

To ascertain the ontogeny of CSF sink action on a small hydrophilic solute, we investigated the rate and extent of uptake of [14C]urea by lateral ventricle choroid plexus (CP), cisternal cerebrospinal fluid (CSF), cerebral cortex, and cerebellum in 0.5- to 4-wk-old etherized nephrectomized rats. Five hours after ip injection, radiourea penetrated the entire H2O of tissue and CSF in 1-wk-old brain; moreover, for animals 1-4 wk old there was a marked inverse relationship between age and magnitude of steady-state [14C]urea space in all regions. However, there was lack of progression (with advancing age) in distribution times to steady state, undoubtedly a reflection of the complexity of maturational factors (CSF secretion, barrier permeability, biphasic changes in cerebral blood flow, etc.) that affect solute penetration into central nervous system. Analysis of [14C]urea uptake curves for various regions at different stages of development (1 vs. 2 wk) revealed half times (slow component) that were significantly greater at 1 wk (1.2-1.4 h) than at 2 wk (0.5-0.8 h). Steady-state concentration gradients for tracer urea, plasma to CP to CSF, indicated negligible molecular sieving of urea by CP 1 wk after birth; however, after the 2nd postnatal wk CSF sink action on urea became manifest due to development of CSF secretion and molecular sieving at the blood-CSF and blood-brain barriers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114296     DOI: 10.1152/ajpregu.1982.243.3.R400

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

3.  A developmental analysis of differences in the uptake of [123I]isopropyliodoamphetamine versus 99mTc-pertechnetate by the choroid plexus and brain.

Authors:  R F Yacavone; M L Dyas; C E Johanson
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

Review 4.  Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus.

Authors:  Conrad Johanson; Edward Stopa; Andrew Baird; Hari Sharma
Journal:  J Neural Transm (Vienna)       Date:  2010-10-10       Impact factor: 3.575

5.  Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease.

Authors:  Conrad Johanson; Paul McMillan; Rosemarie Tavares; Anthony Spangenberger; John Duncan; Gerald Silverberg; Edward Stopa
Journal:  Cerebrospinal Fluid Res       Date:  2004-12-10

6.  Multiplicity of cerebrospinal fluid functions: New challenges in health and disease.

Authors:  Conrad E Johanson; John A Duncan; Petra M Klinge; Thomas Brinker; Edward G Stopa; Gerald D Silverberg
Journal:  Cerebrospinal Fluid Res       Date:  2008-05-14

7.  Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus.

Authors:  Kelley E Deren; Jennifer Forsyth; Osama Abdullah; Edward W Hsu; Petra M Klinge; Gerald D Silverberg; Conrad E Johanson; James P McAllister
Journal:  Cerebrospinal Fluid Res       Date:  2009-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.